PMID- 12719583 OWN - NLM STAT- MEDLINE DCOM- 20030604 LR - 20190508 IS - 0022-538X (Print) IS - 1098-5514 (Electronic) IS - 0022-538X (Linking) VI - 77 IP - 10 DP - 2003 May TI - Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha. PG - 5902-10 AB - The practical application of gene therapy as a treatment for cystic fibrosis is limited by poor gene transfer efficiency with vectors applied to the apical surface of airway epithelia. Recently, folate receptor alpha (FR alpha), a glycosylphosphatidylinositol-linked surface protein, was reported to be a cellular receptor for the filoviruses. We found that polarized human airway epithelia expressed abundant FR alpha on their apical surface. In an attempt to target these apical receptors, we pseudotyped feline immunodeficiency virus (FIV)-based vectors by using envelope glycoproteins (GPs) from the filoviruses Marburg virus and Ebola virus. Importantly, primary cultures of well-differentiated human airway epithelia were transduced when filovirus GP-pseudotyped FIV was applied to the apical surface. Furthermore, by deleting a heavily O-glycosylated extracellular domain of the Ebola GP, we improved the titer of concentrated vector severalfold. To investigate the folate receptor dependence of gene transfer with the filovirus pseudotypes, we compared gene transfer efficiency in immortalized airway epithelium cell lines and primary cultures. By utilizing phosphatidylinositol-specific phospholipase C (PI-PLC) treatment and FR alpha-blocking antibodies, we demonstrated FR alpha-dependent and -independent entry by filovirus glycoprotein-pseudotyped FIV-based vectors in airway epithelia. Of particular interest, entry independent of FR alpha was observed in primary cultures of human airway epithelia. Understanding viral vector binding and entry pathways is fundamental for developing cystic fibrosis gene therapy applications. FAU - Sinn, Patrick L AU - Sinn PL AD - Program in Gene Therapy, Department of Pediatrics, University of Iowa College of Medicine, Iowa City, Iowa 52242, USA. FAU - Hickey, Melissa A AU - Hickey MA FAU - Staber, Patrick D AU - Staber PD FAU - Dylla, Douglas E AU - Dylla DE FAU - Jeffers, Scott A AU - Jeffers SA FAU - Davidson, Beverly L AU - Davidson BL FAU - Sanders, David A AU - Sanders DA FAU - McCray, Paul B Jr AU - McCray PB Jr LA - eng GR - P30 DK-54759/DK/NIDDK NIH HHS/United States GR - NS-34568/NS/NINDS NIH HHS/United States GR - HL-51670/HL/NHLBI NIH HHS/United States GR - R01 NS034568/NS/NINDS NIH HHS/United States GR - HL-67623/HL/NHLBI NIH HHS/United States GR - P01 HL051670/HL/NHLBI NIH HHS/United States GR - R01 HL-61460/HL/NHLBI NIH HHS/United States GR - PPG HL-51670/PG/OAPP OPHS HHS/United States GR - F32 HL067623/HL/NHLBI NIH HHS/United States GR - P30 DK054759/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Virol JT - Journal of virology JID - 0113724 RN - 0 (Carrier Proteins) RN - 0 (Folate Receptors, GPI-Anchored) RN - 0 (Receptors, Cell Surface) RN - 0 (Viral Envelope Proteins) SB - IM MH - Animals MH - Carrier Proteins/*metabolism MH - Cats MH - Cell Polarity MH - Cells, Cultured MH - Epithelial Cells/virology MH - Filoviridae/genetics/*metabolism MH - Folate Receptors, GPI-Anchored MH - *Genetic Vectors MH - Humans MH - Immunodeficiency Virus, Feline/genetics/metabolism/*pathogenicity MH - *Receptors, Cell Surface MH - Respiratory System/cytology/*virology MH - *Transduction, Genetic MH - Viral Envelope Proteins/genetics/*metabolism PMC - PMC154009 EDAT- 2003/04/30 05:00 MHDA- 2003/06/05 05:00 PMCR- 2003/05/01 CRDT- 2003/04/30 05:00 PHST- 2003/04/30 05:00 [pubmed] PHST- 2003/06/05 05:00 [medline] PHST- 2003/04/30 05:00 [entrez] PHST- 2003/05/01 00:00 [pmc-release] AID - 2008 [pii] AID - 10.1128/jvi.77.10.5902-5910.2003 [doi] PST - ppublish SO - J Virol. 2003 May;77(10):5902-10. doi: 10.1128/jvi.77.10.5902-5910.2003.